Cloudmd Software Services Stock Revenue
| DOCRFDelisted Stock | USD 0.03 0 8.50% |
CloudMD Software Services fundamentals help investors to digest information that contributes to CloudMD Software's financial success or failures. It also enables traders to predict the movement of CloudMD Pink Sheet. The fundamental analysis module provides a way to measure CloudMD Software's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CloudMD Software pink sheet.
CloudMD |
CloudMD Software Services Company Revenue Analysis
CloudMD Software's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current CloudMD Software Revenue | 102.33 M |
Most of CloudMD Software's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CloudMD Software Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, CloudMD Software Services reported 102.33 M of revenue. This is 98.66% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The revenue for all United States stocks is 98.92% higher than that of the company.
CloudMD Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CloudMD Software's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CloudMD Software could also be used in its relative valuation, which is a method of valuing CloudMD Software by comparing valuation metrics of similar companies.CloudMD Software is currently under evaluation in revenue category among its peers.
CloudMD Fundamentals
| Return On Equity | -0.88 | |||
| Return On Asset | -0.0595 | |||
| Profit Margin | (1.06) % | |||
| Operating Margin | (0.17) % | |||
| Current Valuation | 45.4 M | |||
| Shares Outstanding | 293.29 M | |||
| Shares Owned By Insiders | 1.26 % | |||
| Shares Owned By Institutions | 0.72 % | |||
| Price To Book | 0.47 X | |||
| Price To Sales | 0.29 X | |||
| Revenue | 102.33 M | |||
| Gross Profit | 5.76 M | |||
| EBITDA | (20.91 M) | |||
| Net Income | (30.73 M) | |||
| Cash And Equivalents | 29.7 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 22.13 M | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 1.67 X | |||
| Book Value Per Share | 0.43 X | |||
| Cash Flow From Operations | (21.86 M) | |||
| Earnings Per Share | (0.10) X | |||
| Number Of Employees | 11 | |||
| Beta | 1.59 | |||
| Market Capitalization | 45.15 M | |||
| Total Asset | 327.36 M | |||
| Z Score | 1.2 | |||
| Net Asset | 327.36 M |
About CloudMD Software Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CloudMD Software Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CloudMD Software using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CloudMD Software Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in CloudMD Pink Sheet
If you are still planning to invest in CloudMD Software Services check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CloudMD Software's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |